Glaxo Retrovir
Executive Summary
Company will provide anti-HIV medication zidovudine at reduced cost for reduction of maternal-fetal HIV transmission in developing countries. Epivir (lamivudine), which Glaxo licenses from BioChem Pharma, will also be provided at reduced price for the same application if it proves to be effective, the company says...